ロード中...
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system
Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...
保存先:
| 出版年: | J Orthop Res |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/ https://ncbi.nlm.nih.gov/pubmed/25348612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|